Antiphospholipid Syndrome

Handbook of Systemic Autoimmune Diseases

Volumn 4, Issue , 2005, Pages 59-75

  Branch, D W ^a   Lockshin, M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750464141     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(05)04006-7     Document Type: Review

References (91)

1. Alfirevic Z., Roberts D., and Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 101 (2002) 6-14
2. American College of Obstetricians and Gynecologists (ACOG). 2000a. Thromboembolism in pregnancy. ACOG Practice Bulletin 19. ACOG, Washington, DC.
3. American College of Obstetricians and Gynecologists (ACOG). 2000b. The use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin 18. ACOG, Washington, DC.
4. American College of Obstetricians and Gynecologists (ACOG). 2001. Management of Recurrent Early Pregnancy Loss. American College of Obstetrics Gynecologists Practice Bulletin 24. ACOG, Washington, DC.
5. Arbuckle M.R., James J.A., Kohlhase K.F., Rubertone M.V., Dennis G.J., and Harley J.B. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 54 (2001) 211
6. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., Khamashta M.A., and Shoenfeld Y. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534
7. Asherson R.A., Cervera R., Piette J.-C., Espinosa G., Garcia-Carrasco M., Ramos-Casals M., and Font J. CAPS Registry: a review of 150 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS) [abstract]. Arthritis Rheum. 46 (2002) s218
8. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., Lim E., Lau T.C., Gurjal A., Jedryka-Goral A., Chwalinska-Sadowska H., Dibner R.J., Rojas-Rodriguez J., Garcia-Carrasco M., Grandone J.T., Parke A.L., Barbosa P., Vasconcelos C., Ramos-Casals M., Font J., and Ingelmo M. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355
9. Bates S.M., Greer I.A., Hirsh J., and Ginsberg J.S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl. (2004) 627S-644S
10. Bhandari S., Harnden P., Brownjohn A.M., and Turney J.H. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 91 (1998) 401
11. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I., Tobar A., and Shoenfeld Y. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109 (2002) 797
12. Bordron A., Dueymes M., Levy Y., Jamin C., Ziporen L., Piette J.C., Shoenfeld Y., and Youinou P. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum. 41 (1998) 1738
13. Botet F., Romera G., Montagut P., Figueras J., Carmona F., and Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J. Perinat. Med. 25 (1997) 192-196
14. Branch D.W. Immunologic disease and fetal death. Clin. Obstet. Gynecol. 30 (1987) 295-311
15. Branch D.W. Antiphospholipid antibodies and fetal compromise. Thromb. Res. 114 (2004) 415-418
16. Branch D.W., Dudley D.J., Mitchell M.D., Creighton K.A., Abbott T.M., Hammond E.H., and Daynes R.A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am. J. Obstet. Gynecol. 163 (1990) 210-216
17. Branch D.W., and Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet. Gynecol. 101 (2003) 1333-1344
18. Branch D.W., Peaceman A.M., Druzin M., Silver R.K., El-Sayed Y., Silver R.M., Esplin M.S., Spinnato J., and Harger J. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am. J. Obstet. Gynecol. 182 (2000) 122-127
19. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., and Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol. 80 (1992) 614-620
20. Brewster J.A., Shaw N.J., and Farquharson R.G. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J. Perinat. Med. 27 (1999) 183-187
21. Clark C.A., Spitzer K.A., Goldberg A.S., Laskin A.S., and Laskin C.A. Long-term follow-up of women with autoantibodies and recurrent pregnancy loss (RPL) [abstract]. Arthritis Rheum. 46 (2002) s45
22. Clark C.A., Spitzer K.A., and Laskin C.A. The spectrum of the antiphospholipid syndrome: a matter of perspective. J. Rheumatol. 28 (2001) 1939-1941
23. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., and Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol. 166 (1992) 1318-1323
24. Crowther M.A., Ginsberg J.S., Julian J., Denburg J., Hirsh J., Douketis J., Laskin C., Fortin P., Anderson D., Kearon C., Clarke A., Geerts W., Forgie M., Green D., Costantini L., Yacura W., Wilson S., Gent M., and Kovacs M.J. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 349 (2003) 1133-1138
25. Day H.M., Thiagarajan P., Ahn C., Reveille J.D., Tinker K.F., and Arnett F.C. Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid syndrome-clinical correlations in comparison with other antiphospholipid antibody tests. J. Rheumatol. 25 (1998) 667
26. Derksen R.H., Khamashta M.A., and Branch D.W. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 50 (2004) 1028-1039
27. Dizon-Townson D., Miller C., Sibai B., Spong C.Y., Thom E., Wendel Jr. G., Wenstrom K., Samuels P., Cotroneo M.A., Moawad A., Sorokin Y., Meis P., Miodovnik M., O'sullivan M.J., Conway D., Wapner R.J., and Gabbe S.G. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet. Gynecol. 106 3 (2005) 517-524
28. Edwards M.H., Pierangeli S., Liu X., Barker J.H., Anderson G., and Harris E.N. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96 (1997) 4380-4384
29. Erel H., Erkan D., Lehman T.J., and Prince M.R. Diagnostic usefulness of 3 dimensional gadolinium enhanced magnetic resonance venography in antiphospholipid syndrome. J. Rheumatol. 29 (2002) 1338
30. Erkan D., Merrill J.T., Yazici Y., Sammaritano L., Buyon J.P., and Lockshin M.D. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum. 44 (2001) 1466-1467
31. Farquharson R.G., Quency S., and Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 100 (2002) 408-413
32. Fausett M.B., Vogtlander M., Lee R.M., Esplin M.S., Branch D.W., Rodgers G.M., and Silver R.M. Heparin-induced thrombocytopenia is rare in pregnancy. Am. J. Obstet. Gynecol. 185 (2001) 148-152
33. Gharavi A.E., Pierangeli S.S., and Harris E.N. Origin of antiphospholipid antibodies. Rheum. Dis. Clin. North Am. 27 (2001) 551
34. Gharavi A.E., Sammaritano L.R., Wen J., and Elkon K.B. Induction of antiphospholipid antibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J. Clin. Invest. 90 (1992) 1105
35. Ginsburg K.S., Liang M.H., Newcomer L., Goldhaber S.Z., Schur P.H., Hennekens C.H., and Stampfer M.J. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann. Intern. Med. 117 (1992) 997
36. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., Hollmann T.J., Casali P., Caroll M.C., Wetsel R.A., Lambris J.D., Holers V.M., and Salmon J.E. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112 (2003) 1644-1654
37. Gris J.C., Mercier E., Quere I., Lavigne-Lissalde G., Cochery-Nouvellon E., Hoffet M., Ripart-Neveu S., Tailland M.L., Dauzat M., and Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103 (2004) 3695-3699
38. Guballa N., Sammaritano L., Schwartzman S., Buyon J., and Lockshin M.D. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 43 (2000) 550
39. Harris E.N. Syndrome of the black swan. Br. J. Rheumatol. 26 (1987) 324-326
40. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Pierangeli S.S., Espinola R., Xiaowei L.E., Mao D., Vialpando C.G., and Salmon J.E. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195 (2002) 211-220
41. Horbach D.A., van Oort E., Derksen R.H., and de Groot P.G. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity-discrimination between functional and non-functional anti-prothrombin antibodies. Thromb. Haemost. 79 (1998) 790-795
42. Horlocker T.T., Wedel D.J., Benzon H., Brown D.L., Enneking K.F., Heit J.A., Mulroy M.F., Rosenquist R.W., Rowlingson J., Tryba M., and Yuan C.S. American Society of Regional Anesthesia and Pain Medicine. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Region. Anesth. Pain Med. 28 (2003) 172-197
43. Hynson J.M., Katz J.A., and Bueff H.U. Epidural hematoma associated with enoxaparin. Anesth. Analg. 82 (1996) 1072-1075
44. Jankowski, M., Vreys, I., Wittevrongel, C., Boon, D., Vermylen, J., Hoylaerts, M.F., Arnout, J. 2002. Thrombogenicity of β2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically-induced thrombosis model in the hamster. Blood 2003; 101: 157-162. Epub 2002 Sep 5.
45. Khamashta M.A., Cuadrado M.J., Mujic F., Taub N.A., Hunt B.J., and Hughes G.R.V. The management of thrombosis in the antiphospholipid-antibody syndrome. N. Eng. J. Med. 332 (1995) 993-997
46. Koskela P., Vaarala O., Makitalo R., Palosuo T., and Aho K. Significance of false positive syphilis reactions and anticardiolipin antibodies in a nationwide series of pregnant women. J. Rheumatol. 15 (1998) 70
47. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet. Gynecol. 174 (1996) 1584-1589
48. Levine S.R., Brey R.L., Sawaya K.L., Salowich-Palm L., Kokkinos J., Kostrzema B., Perry M., Havstad S., and Carey J. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann. Neurol. 38 (1995) 119
49. Levy R.A., Gharavi A.E., Sammaritano L.R., Habina L., Qamar T., and Lockshin M.D. Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. J. Rheum. 17 (1990) 1036
50. Levy R.A., Vilela V.S., Cataldo M.J., Ramos R.C., Duarte J.L., Tura B.R., Albuquerque E.M., and Jesus N.R. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10 (2001) 401-404
51. Lima F., Khamashta M.A., Buchanan N.M., Kerslake S., Hunt B.J., and Hughes G.R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 14 (1996) 131-136
52. Lockshin M.D., Druzin M.L., Goei S., Qamar T., Magid M.S., Jovanovic L., and Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N. Engl. J. Med. 313 (1985) 152-156
53. Lockshin M.D., Sammaritano L.R., and Schwartzman S. Brief report: validation of the Sapporo Criteria for antiphospholipid antibody syndrome. Arthritis Rheum. 43 (2000) 440
54. Lockwood C.J., Romero R., Feinberg R.F., Clyne L.P., Coster B., and Hobbins J.C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am. J. Obstet. Gynecol. 161 2 (1989) 369-373
55. Lutters B.C., Derksen R.H., Tekelenburg W.L., Lenting P.J., Arnout J., and de Groot P.G. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J. Biol. Chem. 278 36 (2003) 33831-33838 Epub 2003 June 13
56. Lynch A., Marlar R., Murphy J., Davila G., Santos M., Rutledge J., and Emlen W. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann. Intern. Med. 120 (1994) 470
57. Mak I.Y., Brosens J.J., Christian M., Hills F.A., Chamley L., Regan L., and White J.O. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 87 (2002) 2581
58. Maksimowicz K., Petri M., and Magder L. Predictors of carotid atherosclerosis in systemic lupus erythematosus[abstract]. Arthritis Rheum. 46 (2002) s54
59. Ortel T.L., and Moll S. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann. Intern. Med. 127 (1997) 177
60. Oshiro B.T., Silver R.M., Scott J.R., Yu H., and Branch D.W. Antiphospholipid antibodies and fetal death. Obstet. Gynecol. 87 (1996) 489-493
61. Paidas M.J., Ku D.H., and Arkel Y.S. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin. Perinatol. 31 4 (2004) 783-805 vii
62. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddell H.S., and McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am. J. Obstet. Gynecol. 183 (2000) 1008-1012
63. Pierangeli S.S., Liu X.W., Barker J.H., Anderson G., and Harris E.N. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb. Haemost. 74 (1995) 1361
64. Pierangeli S.S., Vega-Ostertag M., and Harris E.N. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb. Res. 114 (2004) 467-476
65. Pollard J.K., Scott J.R., and Branch D.W. Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet. Gynecol. 80 (1992) 365-368
66. Preston F.E., Rosendaal F.R., Walker I.D., Briet E., Berntorp E., Conard J., Fontcuberta J., Makris M., Mariani G., Noteboom W., Pabinger I., Legnani C., Scharrer I., Schulman S., and van der Meer F.J. Increased fetal loss in women with heritable thrombophilia. Lancet 348 (1996) 913-916
67. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. Br. Med. J. 314 (1997) 253-257
68. Rai R.S., Regan L., Clifford K., Pickering W., Dave M., Mackie I., McNally T., and Cohen H. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum. Reprod. 10 (1995) 2001-2005
69. Rand J.H. Molecular pathogenesis of the antiphospholipid syndrome. Circ. Res. 90 (2002) 29
70. Rand J.H., Wu S., Andree H.A.M., Lockwood C.J., Guller S., Scher J., and Harpel P.C. Pregnancy loss in the antiphospholipid antibody syndrome - a possible thrombogenic mechanism. N. Engl. J. Med. 337 (1997) 154-160
71. Rasmussen A., and Ravn P. High frequency of congenital thrombophilia in women with pathological pregnancies?. Acta Obstet. Gynecol. Scand. 83 (2004) 808-817
72. Roman M.J., Shankar B.A., Davis A., Lockshin M.D., Sammaritano L., Simantov R., Crow M.K., Schwartz J.E., Paget S.A., Devereux R.B., and Salmon J.E. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349 25 (2003) 2399-2406
73. Ruiz-Irastorza G., Khamashta M.A., Hunt B.J., Escudero A., Cuadrado M.J., and Hughes G.R. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch. Intern. Med. 162 (2002) 1164
74. Sammaritano L.R., Gharavi A.E., Soberano C., Levy R.A., and Lockshin M.D. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J. Clin. Immunol. 12 (1992) 27
75. Sammaritano L.R., Ng S., Sobel R., Lo S.K., Simantov R., Furie R., Kaell A., Silverstein R., and Salmon J.E. Anticardiolipin IgG subclasses. Association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum. 40 (1997) 1998
76. Shah N.M., Khamashta M.A., Atsumi T., and Hughes G.R. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 7 (1998) 3
77. Silver R.K., MacGregor S.N., Sholl J.S., Hobart J.M., Neerhof M.G., and Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am. J. Obstet. Gynecol. 169 (1993) 1411-1417
78. Silver R.M., Draper M.L., Scott J.R., Lyon J.L., Reading J., and Branch D.W. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet. Gynecol. 83 (1994) 372
79. Simantov R., Lo S.K., Salmon J.E., Sammaritano L.R., and Silverstein R.L. Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Thromb. Res. 84 (1996) 361-365
80. Spitzer K.A., Clark C.A., Laskin A.S., Goldberg A.S., and Laskin C.A. Prevalence of inherited thrombophilias in women with unexplained recurrent pregnancy loss [abstract]. Arthritis Rheum. 46 (2002) s231
81. Stephenson M.D. Frequency of factors associated with habitual abortion in 197 couples. Fertil. Steril. 66 (1996) 24
82. Stern J.J., Dorfmann A.D., Gutierrez-Najar A.J., Cerrillo M., and Coulam C.B. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. 65 (1996) 250-253
83. Sullivan A.E., Silver R.M., LaCoursiere D.Y., Porter T.F., and Branch D.W. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet. Gynecol. 104 (2004) 784-788
84. The Antiphospholipid Antibody Stroke Study (APASS) Group. 1993. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 43, 2069.
85. Triolo G., Ferrante A., Ciccia F., Accardo-Palumbo A., Perino A., Castelli A., Giarratano A., and Licata G. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum. 48 (2003) 728-731
86. Vilela V.S., de Jesus N.R., and Levy R.A. Prevention of thrombosis during pregnancy. Isr. Med. Assoc. J. 4 10 (2002) 794-797
87. Vossen C.Y., Preston F.E., Conard J., Fontcuberta J., Makris M., van der Meer F.J., Pabinger I., Palareti G., Scharrer I., Souto J.C., Svensson P., Walker I.D., and Rosendaal F.R. Hereditary thrombophilia and fetal loss: a prospective follow-up study. J. Thromb. Haemost. 2 (2004) 592-596
88. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.-C., Brey R., Derksen R., Harris E.N., Hughes G.R.V., Triplett D.A., and Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum. 42 (1999) 1309-1311
89. Yasuda M., Takakuwa K., Tokunaga A., and Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet. Gynecol. 86 (1995) 555-559
90. Yetman D.L., and Kutteh W.H. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil. Steril. 66 (1996) 540-546
91. Yin B., Barratt S.M., Power I., and Percy J. Epidural haematoma after removal of an epidural catheter in a patient receiving high-dose enoxaparin. Br. J. Anaesth. 82 (1999) 288-290